AONN+ and Gilead Sciences Collaborate to Enhance Oncology Navigation Through Grant Initiative

AONN+ Partners with Gilead Sciences for a New Grant Program

In a significant move aimed at improving oncology care, the Academy of Oncology Nurse & Patient Navigators (AONN+) is thrilled to unveil a transformative grant program in collaboration with Gilead Sciences. This initiative focuses on enhancing oncology navigation and patient outcomes, a critical area in healthcare that remains a challenge due to numerous systemic barriers.

The grant program's primary aim is to support the development and enhancement of innovative tools and practices that optimize the performance of oncology navigators, thus improving patient access to crucial navigation services. As emphasized by AONN+ Executive Director, Candice Roth, the funding enables navigators to tackle persistent challenges in cancer care. "By empowering navigators to improve access, remove barriers to cancer treatment, and bolster adherence to treatment plans, we enhance the overall patient experience," Roth stated.

Grant Application Insights

Since the grant application call in April, healthcare leaders nationwide have risen to the occasion, submitting creative proposals focused on software solutions and healthcare system improvements. AONN+ will announce the award recipients in June, with project work expected to commence in July. Those awarded grants could receive funding of up to $500,000. The implementation of this project is aimed to effectively integrate proposed tools with measurable improvements in patient care, ensuring that navigators can wield significant impact in their roles.

"Navigator utilization is key to optimizing patient outcomes, and this grant will create impactful solutions by strategically linking innovative proposals with tangible results in cancer care," added Roth.

Gilead's Commitment to Oncology

Darren Tayama, M.D., Vice President of US Medical Affairs at Gilead, also expressed excitement regarding the partnership, stating, "Through Gilead's Community Cancer Collective, we are proud to support AONN+ in this initiative to advance the future of oncology care. Together, we are committed to developing innovative oncology navigation solutions that will benefit the entire cancer community."

About AONN+

The Academy of Oncology Nurse & Patient Navigators is the largest national specialty organization focused on improving patient care and quality of life for individuals going through cancer treatment. Since its founding in 2009, AONN+ has expanded to include over 9,000 members dedicated to enhancing the roles of oncology nurse and patient navigators across various healthcare sectors. The organization emphasizes the importance of a cohesive network for professionals working in patient navigation and survivorship care.

About Gilead Sciences

Gilead Sciences, established over three decades ago, is a biopharmaceutical company that strives to create a healthier world by discovering and producing innovative medicines to combat life-threatening diseases, including cancer, HIV, and COVID-19. Operating in more than 35 countries around the world, Gilead's continuous commitment to advancing medical breakthroughs underlines its importance in the industry.

Conclusion

With the launch of this innovative grant program, AONN+ and Gilead Sciences are set to make a lasting impact in the field of oncology navigation. By equipping navigators with essential tools and support, the partnership aims to elevate patient outcomes and streamline the cancer treatment process, making strides toward a more effective healthcare landscape for all.